FULGENT GENETICS, INC. (FLGT) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD $524.10M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.92M; Retained Earnings (Accumulated Deficit)USD $475.60M.
- 2026-03-31: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD $540.14M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $4.54M; Retained Earnings (Accumulated Deficit)USD $505.13M.
- 2025-12-31: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in Capital, Common StockUSD $574.52M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $7.51M; Retained Earnings (Accumulated Deficit)USD $529.95M.
- 2025-09-30: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in Capital, Common StockUSD $565.69M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $6.82M; Retained Earnings (Accumulated Deficit)USD $553.37M.
FULGENT GENETICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Noncontrolling Interest, Increase from Business Combination USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.00K | $524.10M | $1.92M | $475.60M | $1.00B | $995.99M | 3 month · $8.62M | (m) | (m) |
| 2026-03-31 | $4.00K | $540.14M | $4.54M | $505.13M | $1.05B | $1.04B | 3 month · $9.89M | (m) | (m) |
| 2025-12-31 | $3.00K | $574.52M | $7.51M | $529.95M | $1.11B | $1.11B | 12 month · $39.58M | (m) | (m) |
| 2025-09-30 | $3.00K | $565.69M | $6.82M | $553.37M | $1.13B | $1.12B | 3 month · $9.72M | (m) | (m) |
| 2025-06-30 | $3.00K | $550.60M | $6.00M | $559.98M | $1.12B | $1.11B | 3 month · $10.04M | (m) | (m) |
| 2025-03-31 | $3.00K | $543.90M | $4.33M | $578.94M | $1.13B | $1.12B | 3 month · $10.55M | (m) | (m) |
| 2024-12-31 | $3.00K | $543.13M | $-368.00K | $590.47M | $1.13B | $1.13B | 12 month · $44.48M | (m) | (m) |
| 2024-09-30 | $3.00K | $532.91M | $9.18M | $596.36M | $1.14B | $1.13B | 3 month · $10.92M | (m) | (m) |
| 2024-06-30 | $3.00K | $522.42M | $-877.00K | $611.00M | $1.13B | $1.13B | 3 month · $11.63M | (m) | (m) |
| 2024-03-31 | $3.00K | $511.33M | $-1.10M | $619.71M | $1.13B | $1.13B | 3 month · $11.52M | (m) | (m) |
| 2023-12-31 | $3.00K | $501.72M | $1.21M | $633.17M | $1.14B | $1.13B | 12 month · $42.92M | (m) | (m) |
| 2023-09-30 | $3.00K | $514.26M | $-16.89M | $761.32M | $1.26B | $1.26B | 3 month · $10.90M | (m) | (m) |
| 2023-06-30 | $3.00K | $506.07M | $-20.75M | $774.43M | $1.26B | $1.26B | 3 month · $10.32M | (m) | (m) |
| 2023-03-31 | $3.00K | $495.98M | $-17.20M | $785.66M | $1.26B | $1.27B | 3 month · $10.27M | (m) | (m) |
| 2022-12-31 | $3.00K | $486.58M | $-20.90M | $801.00M | $1.27B | $1.27B | 12 month · $32.64M | (m) | (m) |
| 2022-09-30 | $3.00K | $477.81M | $-25.60M | $824.83M | $1.28B | $1.28B | 3 month · $8.97M | (m) | (m) |
| 2022-06-30 | $3.00K | $504.07M | $-22.42M | $823.11M | $1.30B | $1.31B | 3 month · $8.03M | (m) | (m) |
| 2022-03-31 | $3.00K | $507.05M | $-12.49M | $811.58M | $1.31B | $1.31B | 3 month · $5.62M | (m) | (m) |
| 2021-12-31 | $3.00K | $501.91M | $-759.00K | $657.60M | $1.16B | $1.17B | 12 month · $15.88M | (m) | 12 month · $8.15M |
| 2021-09-30 | $3.00K | $483.73M | $-212.00K | $553.26M | $1.04B | $1.04B | 3 month · $4.37M | (m) | (m) |
| 2021-06-30 | $3.00K | $482.25M | $-265.00K | $430.74M | $912.73M | $920.73M | 3 month · $3.53M | (m) | 3 month · $8.15M |
| 2021-03-31 | $3.00K | $450.86M | $-216.00K | $350.92M | $801.57M | $801.57M | 3 month · $2.96M | (m) | (m) |
| 2020-12-31 | $3.00K | $418.06M | $438.00K | $150.88M | $569.39M | $569.39M | 12 month · $8.16M | (m) | (m) |
| 2020-09-30 | $2.00K | $201.77M | $607.00K | $-15.43M | $186.96M | $186.96M | 3 month · $3.15M | (m) | (m) |
| 2020-06-30 | $2.00K | $148.06M | $1.05M | $-62.06M | $87.04M | $87.04M | 3 month · $1.08M | (m) | (m) |
| 2020-03-31 | $2.00K | $146.95M | $-193.00K | $-65.39M | $81.37M | $81.37M | 3 month · $924.00K | (m) | (m) |
| 2019-12-31 | $2.00K | $146.06M | $146.00K | $-63.43M | $82.78M | $82.78M | 12 month · $3.21M | (m) | (m) |
| 2019-09-30 | $2.00K | $117.48M | $179.00K | $-63.13M | $54.53M | (m) | 3 month · $951.00K | (m) | (m) |
| 2019-06-30 | $2.00K | $115.53M | $203.00K | $-64.59M | $51.14M | (m) | 3 month · $737.00K 6 month · $1.32M | (m) | (m) |
| 2019-03-31 | $2.00K | $114.79M | $95.00K | $-64.93M | $49.96M | (m) | 3 month · $583.00K | (m) | (m) |
| 2018-12-31 | $2.00K | $114.20M | $-35.00K | $-63.02M | $51.15M | $51.15M | 12 month · $2.30M | (m) | (m) |
| 2018-09-30 | $2.00K | $113.60M | $-57.00K | $-60.97M | $52.58M | (m) | 3 month · $588.00K 9 month · $1.71M | (m) | (m) |
| 2018-06-30 | $2.00K | $113.01M | $-82.00K | $-60.37M | $52.56M | (m) | 3 month · $573.00K 6 month · $1.12M | (m) | (m) |
| 2018-03-31 | $2.00K | $112.43M | $-87.00K | $-59.32M | $53.02M | (m) | 3 month · $545.00K | (m) | (m) |
| 2017-12-31 | $2.00K | $111.88M | $-44.00K | $-57.66M | $54.18M | (m) | 12 month · $2.12M | (m) | (m) |
| 2017-09-30 | $2.00K | $111.30M | $10.00K | $-56.04M | $55.27M | (m) | 9 month · $1.54M | (m) | (m) |
| 2017-06-30 | $2.00K | (m) | $-68.00K | $-54.95M | $55.73M | (m) | 6 month · $989.00K | $110.75M | (m) |
| 2017-03-31 | $2.00K | (m) | $-85.00K | $-54.92M | $55.30M | (m) | 3 month · $565.00K | $110.30M | (m) |
| 2016-12-31 | $2.00K | $109.73M | $-103.00K | $-55.15M | $54.48M | (m) | (m) | $109.73M | (m) |
| 2016-09-30 | $1.00K | (m) | (m) | $-55.97M | $17.25M | (m) | (m) | $73.21M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $-53.16M | $5.15M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | $1.68M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $1.97M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |